HOWL · Werewolf Therapeutics, Inc.
$0.35
-0.15 (-29.38%)
At close · Jul 31
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe there is substantial doubt about our ability to continue as a going concern for at least twelve months from the date that these condensed consolidated financial statements are issued in this Quarterly Report.”View the 10-Q filed Jul 31, 2026
Market Cap
$17.16M
Shares
48.60M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | CEO | $2,545,599 |
| Randi Isaacs | Chief Medical Officer | $1,440,024 |
| Timothy W. Trost | CFO | $1,216,560 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | CEO | $1,366,904 |
| Randi Isaacs | Chief Medical Officer | $855,765 |
| Timothy W. Trost | CFO | $815,585 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | CEO | $2,474,896 |
| Randi Isaacs | Chief Medical Officer | $1,218,819 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | $1,210,878 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chulani Karunatilake | CTO | $3,863,682 |
| Daniel J. Hicklin | CEO | $2,462,548 |
| Timothy W. Trost | CFO | $2,090,049 |
| Randi Isaacs | Chief Medical Officer | $1,310,253 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | $1,186,721 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | CEO | $2,989,923 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Urban | principal financial officer and principal accounting officer | Appointed | 2026-02-13 |
| Randi Isaacs | Chief Medical Officer | Resigned | 2026-02-13 |
| Timothy W. Trost | Chief Financial Officer | Resigned | 2026-02-13 |
| Anil Singhal, Ph.D. | director | Appointed | 2025-02-24 |
| Derek DiRocco, M.D. | Director | Resigned | 2025-02-24 |